People

Swander Pace's aden + anais parts ways with CEO Moya-Jones

Scott Kania has succeeded Raegan Moya-Jones as CEO of aden + anais, a company spokeswoman said in an email to Buyouts. Moya-Jones, who founded aden + anais, is no longer part of the company’s day-to-day, the message said. Swander Pace Capital acquired a majority of aden + anais, which is known for its muslin baby swaddles, in 2014, PitchBook said. Kania will continue to oversee aden + anais’ HR, operations/logistics, IT and the international regions; he will also be responsible for the overall direction and performance of the business, the spokeswoman said. The email confirms a March 20 report from Mergermarket, which said Moya-Jones didn’t agree with the direction of aden + anais’ business and was let go on March 14. Mergermarket is part of Acuris.

Five Questions with Tom Baruch of Baruch Future Ventures, a family office

Peterson, Blackstone co-founder, passes away: Associated Press

Pete Peterson, who co-founded Blackstone Group in 1985 with Stephen Schwarzman, has passed away, according to the Associated Press. Peterson, 91, died of natural causes, the story said. Peterson was head of two major companies before he helped launch Blackstone. In the 1960s, he was CEO of Bell and Howell, which made movie cameras at the time. Peterson took over as head of Lehman Brothers in 1973, the AP said. Blackstone’s IPO in 2007 made Peterson a billionaire.

PE-owned Brammer Bio adds three to team

Brammer Bio, which is owned by Ampersand Capital Partners, has named Doug Chambers as vice president, quality and regulatory. Previously, Chambers held quality and compliance leadership roles at Millipore Sigma and Merck Research Laboratories. Also, Brammer has hired Dana Alexander as site head for Brammer's late phase and commercial viral vector manufacturing site in Cambridge, Massachusetts and Larry Pitcher as site head for its early-clinical development and viral vector manufacturing facilities in Alachua, Florida. Brammer is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies.

Hurd joins Cressey & Co

Andy Hurd has joined Cressey & Co LP as an operating partner. Hurd most recently served as CEO of MedeAnalytics.

Hooper named CEO of Tri-Tex

Tri-Tex said March 20 that Richard Hooper was named CEO of the company. Hooper most recently served as CEO of SummitReheis. Hooper assumes the role from Natalie Laham, who will remain with the company as a minority shareholder and member of the Board of Directors.

Nowell joins PGIM

Howard Nowell has joined PGIM as managing director of the company’s institutional relationship group in London. PGIM is the investment management businesses of Prudential Financial Inc. Nowell was most recently a managing director with BlackRock’s institutional client business in the U.K.

ASGARD names Machen to helm new Boston office

ASGARD Partners & Co has appointed Christopher Machen to head its new Boston office. Machen will also serve as a senior member of the firm's advisory group. Previously, Machen worked at GCP Applied Technologies where he was director of corporate development and strategy.

BIS recruits McRaith as MD

Blackstone Insurance Solutions has named Michael McRaith as a managing director. McRaith is a former director of the U.S. Department of the Treasury's Federal Insurance Office under the Obama administration.

Cynosure taps Hunter as MD and investor relations head

Salt Lake City-based The Cynosure Group, a private equity firm, has appointed David Hunter as a managing director and head of investor relations. Previously, Hunter worked at Partners Group.